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The last 5 years have seen a remarkable 
extension of the innate immune system 
starting with what seemed at the time pri-
marily cells that exert their influence during 
ontogeny of the immune system. So-called 
lymphoid tissue inducer (Lti) cells were 
soon joined by RORgt expressing innate 
lymphoid cells (ILC) that shaped immune 
responses beyond the determination of 
lymphoid architecture (Sawa et al., 2010). 
The latest addition to the growing family 
of ILC are characterized by the production 
of T helper (Th) 2-type cytokines even in 
the absence of the adaptive immune system 
(Moro et al., 2010; Neill et al., 2010; Price 
et al., 2010; Saenz et al., 2010).
T helper 2-type cytokine responses play 
a major role in the immunity to parasitic 
helminth infections, but are also implicated 
in the development of allergic diseases such 
as asthma (Paul and Zhu, 2010). The hall-
mark of Th2 mediated immune responses 
is the activation of mast cells, eosinophils, 
basophils, and goblet cell hyperplasia medi-
ated by the cytokines IL-5, IL-9, and IL-13. 
Until recently, T cells of the Th cell type 2 
(Th2) subset were thought to be the most 
abundant and important source of these 
cytokines. However, it became clear that a 
group of innate cells exist, that lack conven-
tional markers typical for main lymphoid 
cell types and are able to produce high 
amounts of Th2-type cytokines (Fort et al., 
2001; Hurst et al., 2002; Fallon et al., 2006). 
Such responses were shown to be depend-
ent on the epithelial cell derived cytokine 
IL-25. More recently those ILC popula-
tions were further characterized by four 
independent research groups and called 
natural helper cells (NHCs; Moro et al., 
2010), nuocytes (Neill et al., 2010), innate 
helper type 2 (Ih2) cells (Price et al., 2010), 
or multipotent progenitors (MPPs; Saenz 
et al., 2010). Nuocytes and MPPs reside in 
mesenteric lymph nodes and spleen, NHCs 
are found in the fat-associated lymphoid tis-
sue and Ih2 cells are dispersed throughout 
the body, with most Ih2 cells recovered from 
the liver. All studies in support of earlier 
work established an important role for ILC 
as IL-25 but also IL-33 dependent cells in 
the context of helminth infections. In a 
recent review those newly discovered cells 
were classified as innate helper cells type 2 
(ILC2; Spits and Di Santo, 2011) compared 
with RORγt expressing ILC subsets linked 
to cytokines such as IL-17 and IL-22 (ILC17 
and ILC22). Lately, our own studies using 
an IL-9 fate reporter mouse model estab-
lished that besides the Th2-type cytokines 
IL-5, IL-6, and IL-13 ILC2 also produce IL-9 
(Wilhelm et al., 2011). However unlike IL-5 
and IL-13 production in ILC, IL-9 is not 
permanently expressed but characterized 
by a very transient IL-2 dependent expres-
sion profile thus extending the portfolio of 
cytokines released by ILC.
Surface marker expreSSion by iLc
Despite their obvious similarities all newly 
discovered ILC populations were given dif-
ferent names based on differential expres-
sion of surface markers. Interestingly, this 
variation is limited to surface markers 
indicative of the activation state of cells. For 
example CD25 and Sca-1 are upregulated 
on T cells upon activation or differentiation. 
Thus, it is conceivable that the activation 
state or tissue distribution of the various 
innate lymphoid populations might influ-
ence the expression of surface receptors, as 
recently observed for nuocytes (Neill and 
Mckenzie, 2011). Indeed our own unpub-
lished data suggests that ILC, which have 
expressed the IL-9 gene and are marked 
by eYFP expression (eYFP+ ILC), display 
variations of surface marker expression 
before and directly after papain challenge. 
Differences in the surface phenotype are 
also observed in ILC induced by intrana-
sal delivery of either IL-25 or IL-33. While 
challenge with IL-33 induces ILC displaying 
an activated phenotype, with high expres-
sion of CD25 and Sca-1, IL-25 elicited 
ILC are low for those activation markers 
(our unpublished data). Interestingly, ILC 
 generated by delivery of IL-33 are also more 
potent producers of IL-9 upon IL-2 stimula-
tion, suggesting that their activation state 
could influence the ability to produce IL-9.
DepenDency on the aDaptive 
immune SyStem (figure 1)
Another important but less explored find-
ing is the observation that ILC may depend 
on the adaptive immune system for mainte-
nance or expression of cytokines. This is best 
illustrated by the fact that nuocyte numbers 
(identified by IL-13 via GFP expression) in 
Rag−/− mice are greatly reduced at day 6 but 
not at day 4 after Nippostrongylus brasiliensis 
infection in contrast to nuocytes induced in 
wild-type mice (Neill et al., 2010). There are 
two possible interpretations for this effect: 
Either nuocytes, while readily induced are 
not maintained in absence of the adap-
tive immune system or alternatively their 
characteristic cytokine expression is lost. 
Since the classification as nuocytes in this 
particular setting depended on continuous 
IL-13 expression monitored by GFP, loss of 
cytokine expression might erroneously be 
interpreted as loss of the whole population.
The latter assumption is supported by 
data from our laboratory in the context 
of papain mediated lung inflammation. 
Similar to the report from McKenzie et al. 
(1998) we observed reduced levels of IL-13 
expression in Rag−/− mice in the absence of 
the adaptive immune system. Importantly 
though, we did not observe a significant loss 
of ILC in Rag−/− mice based on the classifi-
cation as lineage− Thy1.2+ cells. Since IL-9 
promotes expression of IL-5 and IL-13 from 
ILC and IL-2 induces IL-9, the lack of IL-2 
from adaptive immune cells (or NKT cells), 
and the resulting loss of IL-9 expression is 
one possible explanation for reduced Th2-
type cytokine expression in Rag−/− mice. In 
line with this assumption, delivering either 
exogenous IL-2 or IL-9 to Rag−/− mice in 
the context of allergen challenge resulted 
likewise in increased levels of IL-5 and IL-13 
(unpublished data). However, delivery of 
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response (Neill et al., 2010; Price et al., 
2010). However, whether ILC are needed 
for the induction of an adaptive type 2 
immune response and/or whether they 
represent the critical and main source of 
cytokine producers during such immune 
responses is unknown. These questions are 
not trivial to address. While the initiation of 
the ILC response develops independent of 
the adaptive immune system, their mainte-
nance requires adaptive immune cells. Here 
the study of Rag−/− mice can only deliver 
insufficient answers.
In a model of papain induced lung 
inflammation the majority of Th2-type 
cytokine producing cells originated from 
ILC despite the presence of fully developed 
Th2 cells (Wilhelm et al., 2011). Here we 
attempted to address the relative contribu-
tion to the overall amount of IL-9 by trans-
ferring either CD4+ T cells or ILC to naïve 
the past, ablation of adaptive immune cells 
was believed to only affect adaptive sources 
of cytokine production. Since expression of 
cytokines from ILC depends on the adaptive 
immune system, it is conceivable that stud-
ies exploring the effect of T cell mediated 
cytokine expression unknowingly targeted 
cytokine expression from ILC simultane-
ously. In addition, antigen specific cytokine 
expression has been widely addressed by the 
restimulation of total splenocytes or lym-
phocytes with antigen in tissue culture. The 
presence of T cell (or NKT cell-) derived IL-2 
in these cultures most likely will result in the 
induction of cytokine expression by ILC. This 
example clearly demonstrates that the cellular 
sources of cytokines have to be readdressed in 
the majority of experimental disease models.
It appears that the initiation of ILC 
happens around day 3–5 in an immune 
response, thus preceding the adaptive 
IL-25 to N. brasiliensis infected Rag−/− mice 
results in the rapid expulsion of worms, 
whereas such mice are normally highly 
susceptible to helminth infections (Price 
et al., 2010). Similar results are observed if 
Rag−/− IL2rg−/− (mice which lack ILC in addi-
tion to being deficient for T, B, and NK cells) 
are transferred with ILC and treated with 
IL-25 (Price et al., 2010). This suggests that 
continuous exposure to IL-25 and probably 
IL-33 is able to circumvent the dependency 
of the adaptive immune system and to sub-
stitute for IL-2 presence.
What iS the reLative contribution 
of iLc to the overaLL amount of 
type 2 cytokineS?
The described dependency on the adap-
tive immune system either for cytokine 
expression or survival/maintenance is one 
of the most intriguing features of ILC. In 
Figure 1 | induction of innate lymphoid cell responses. Helminths, 
allergens, and viruses cause epithelial tissue damage resulting in the release of 
epithelial derived IL-33 and IL-25. Resident ILC populations are either activated 
and/or expand in response to IL-33 and IL-25 or are newly recruited to sites of 
inflammation. Primed/expanded/recruited ILC release IL-5, IL-13, and 
amphiregulin, while displaying variations of the surface molecules CD25, Thy1.2, 
IL9R, cKit, Sca-1, IL17RB, and IL-33R dependent on their tissue distribution and 
activation status. Soluble factors released by ILC promote recruitment of 
eosinophils and features of airway hyperreactivity such as mucus production and 
tissue remodeling/repair. In addition, exposure to helminthes, viruses, and 
allergens results in antigen recognition and T cell activation (CD4, CD8, and NKT 
cells). T cell activation in turn leads to the release of IL-2, which induces transient 
IL-9 expression from ILC further enhancing/maintaining IL-5 and IL-13 expression 
thus possibly contributing to augmented worm expulsion.
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such ILC functions have just evolved as 
mirror images of those in adaptive T cells. A 
consideration is the potential of adaptive T 
cell responses to cause immune pathology 
or autoimmune syndromes. Although ILC 
responses have in some cases been shown to 
have detrimental effects (Buonocore et al., 
2010; Chang et al., 2011) these studies by 
necessity had to be done in relatively con-
trived experimental models with immuno-
compromised mice, thus not necessarily 
reflecting similar pathogenic actions of ILC 
in wild-type mice. It therefore remains a 
possibility that immune responses by ILC 
are a first line of defense coupled with 
regenerative potential, whereas exacer-
bation and disbalance toward pathology 
would only be encountered following the 
involvement of adaptive T cells. To test any 
such predictions it would be necessary to 
develop experimental systems that would 
allow the inducible deletion of just ILC 
rather than the current models that can 
only study ILC function in the absence of 
an adaptive immune system.
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iLc reSponSeS in humanS
The first evidence for the presence of ILC in 
humans showed that NHC similar to those 
of the mouse are present in human fat-
associated lymphoid clusters (FALC; Moro 
et al., 2010). Another, more recent study 
demonstrated that nasal polyps isolated 
from patients with atopic disease contain 
increased numbers of ILC (Mjosberg et al., 
2011). These cells were characterized by the 
expression of the chemoattractant receptor 
CRTH2 (chemoattractant receptor-homol-
ogous molecule expressed on Th2 lympho-
cytes), were present in lung, gut, and nasal 
tissues and produced IL-13 in response to 
stimulation with combinations of IL-2 and 
IL-25 or IL-33. This strongly suggests that 
similar mechanism for the induction of ILC 
in mouse and human exists and highlights 
their potential in atopic diseases like asthma 
and allergies.
future DirectionS
While the accumulation of ILC has been 
shown to depend on IL-25 and/or IL-33, it 
is not entirely clear if IL-25 and IL-33 expo-
sure lead to their recruitment or expansion. 
In vitro studies suggest that combinations 
of IL-33 and IL-2 or IL-7 are able to expand 
the pool of existing ILC. However it remains 
unknown if ILC are recruited from other 
sites of the body like liver or bone mar-
row during an ongoing immune response. 
Additionally, no data is available with regard 
to which progenitor cells give rise to ILC.
Finally, the evolutionary origin of ILC 
remains an interesting as yet unsolved ques-
tion. Did ILC appear before the develop-
ment of the adaptive immune system, or 
did ILC and the adaptive immune system 
co-evolve as their dependency on the adap-
tive immune system might suggest? These 
questions will be hopefully addressed in the 
future to further help to shape our under-
standing of this intriguing subset of innate 
lymphocytes.
concLuDing remarkS about the 
phySioLogicaL roLe of iLc in 
generaL
It appears that ILC play an important role 
not only in the initiation and effector phase 
of an immune response but also in the 
resolution of inflammation and the tissue 
repair process. Most of these functions are 
also attributed to T cells and T cell derived 
cytokines. However, it seems unlikely that 
Rag−/−IL2rg−/− mice, thus limiting IL-9 pro-
duction to either transferred CD4+ T cells 
or ILC. Despite the shortcomings of this 
experimental system, it clearly established 
that ILC are indeed the major producers of 
cytokines in this particular disease model. 
However, the question remains if we can 
relate these findings to other experimen-
tal systems and it needs to be addressed if 
type 2 cytokines produced during helminth 
infections, influenza or other disease mod-
els mainly originate from T cells or ILC. 
In line with the assumption that ILC are 
the major source of type 2 cytokines, an 
elegant set of experiments showed that the 
transfer of CD4+ T cells from il4/il13−/− mice 
to Rag−/− mice, was sufficient to result in 
expulsion of N. brasiliensis from infected 
mice (Voehringer et al., 2006). Thus, the 
need for T cells was emphasized, but 
these could not have provided the critical 
source of IL-13, which is absolutely cru-
cial for worm expulsion (Mckenzie et al., 
1998; Urban et al., 1998). Further stud-
ies are needed to clearly establish the link 
between the adaptive immune system and 
the regulation of ILC in different experi-
mental models.
the function of iLc in infLuenza 
infection
Two recent studies explored the function of 
lung resident ILC in the context of influ-
enza infection (Chang et al., 2011, p. 103; 
Monticelli, 2011, p 170). The first study 
explored the function of innate lympho-
cytes during the early phase of influenza 
infection and established that obstruc-
tion of the airways during flu infections 
seems to be dependent on IL-13 by ILC. 
Interestingly, a second study that focused on 
the late phase after infection suggested an 
important role for ILC in the maintenance 
of airway epithelial integrity, showing that 
ablation of ILC in Rag−/− mice during the 
repair phase after influenza mediated lung 
infection leads to diminished lung function 
and impaired airway remodeling in mice. 
This process appeared to be independ-
ent of IL-13. However, administration of 
amphiregulin was able to restore airway 
epithelial integrity and tissue homeosta-
sis, thus suggesting a previously unrecog-
nized function of ILC via the expression 
of amphiregulin. The involvement – if 
any – of IL-9 in these processes remains to 
be addressed.
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